Research status of anti-COVID-19 mutation drugs

COVID-19 is a virus with high genetic variation, and many variants have appeared. Therefore, it is very important to study drugs that can effectively resist COVID-19 variants.

At present, the main research on COVID-19 mutation resistance focuses on the following aspects:

Vaccine: Vaccines that can resist COVID-19 varieties have been developed, such as Moderna and Pfizer-Biotechnology Company's vaccines, and these vaccines have shown certain immune effects on varieties in experiments.

Antiviral drugs: Researchers are developing antiviral drugs that can effectively resist COVID-19 varieties, such as Redixivir and Farpiravir.

Immunotherapy: Researchers are studying immunotherapy, such as humanized antibody's therapy, which can improve the immune system's resistance to COVID-19 variety.